Author

Bei Wang

Institution: Genentech

Observed institution: Genentech

ORCID: 0009-0002-7992-6414

Observed ORCID: 0009-0002-7992-6414

OpenAlex ID: A5100716644

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

2012 · Sandhya Girish, Manish Gupta, et al. · Cancer Chemotherapy and Pharmacology · 262

Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies

2019 · Chunze Li, Cindy Zhang, et al. · mAbs · 61

Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro

2008 · Shu-Ying Chang, Wenying Li, et al. · Drug Metabolism and Disposition · 61

An Integrated Multiple-Analyte Pharmacokinetic Model to Characterize Trastuzumab Emtansine (T-DM1) Clearance Pathways and to Evaluate Reduced Pharmacokinetic Sampling in Patients with HER2-Positive Metastatic Breast Cancer

2013 · Dan Lu, Amita Joshi, et al. · Clinical Pharmacokinetics · 42

Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics

2016 · Siddharth Sukumaran, Crystal Zhang, et al. · The AAPS Journal · 27

Works count: 5

Citation count: 453

H-index: 5

I10-index: 5